UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
July 16, 2004
Date of report (date of earliest event reported)
QUADRAMED CORPORATION
(Exact Name of Registrant as Specified in Charter)
Delaware | 0-21031 | 52-1992861 | ||
(State or Other Jurisdiction of Incorporation) |
(Commission File Number) | (IRS Employer Identification No.) |
12110 Sunset Hills Road, Suite 600, Reston, VA 20190
(Address of Principal Executive Offices)
(703) 709-2300
(Registrants telephone number, including area code)
Not Applicable
(Former Name or Former address, if Changed Since Last Report)
ITEM 5. | OTHER EVENTS AND REGULATION FD DISCLOSURE | |
ITEM 7. | FINANCIAL STATEMENTS AND EXHIBITS | |
SIGNATURES | ||
EXHIBIT INDEX | ||
EXHIBIT 99.1 |
ITEM 5. OTHER EVENTS AND REGULATION FD DISCLOSURE
On July 20, 2004, QuadraMed Corporation announced the completion of its cash tender offer to purchase any and all of its outstanding 10% Senior Secured Notes due 2008 (the Notes). All of the Notes were purchased, the aggregate purchase price including accrued and unpaid interest was approximately $79.3 million. A copy of the Press Release is attached to this Current Report on Form 8-K as Exhibit 99.1.
The information in this Current Report on Form 8-K is being furnished and shall not be deemed filed for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section. The information in this Current Report shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such a filing.
ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS
(c) | Exhibits |
Exhibit No. |
Description | |
99.1 | Press Release, dated July 20, 2004, announcing completion of QuadraMeds tender offer with respect to its 10% Senior Secured Notes due 2008. |
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: July 20, 2004
QuadraMed Corporation |
/s/ |
John Wright, Executive Vice President, Chief Financial Officer and Secretary |
Exhibit No. |
Description | |
99.1 | Press Release, dated July 19, 2004, announcing completion of QuadraMeds tender offer with respect to its 10% Senior Secured Notes due 2008. |